Showing results (11-20 of 384) with videos related to
Sort By:
Pageof 39
Future Oncology (London, England)|October 3, 2022
On the road to improved outcomes by capturing leiomyosarcoma patients' viewsRobin L JonesAnticancer Research|October 1, 2021
Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma - A Single Centre Retrospective AnalysisGerard M Walls, Shane H Zaidi, Nicos Fotiadis, et al.Medical Oncology (Northwood, London, England)|April 15, 2010
Chemotherapy in clear cell sarcomaRobin L Jones, Anastasia Constantinidou, Khin Thway, et al.The Lancet. Oncology|December 17, 2008
Eligibility of patients with brain metastases for phase I trials: time for a rethink?Craig P Carden, Roshan Agarwal, Frank Saran, et al.Translational Gastroenterology and Hepatology|May 22, 2018
Perspectives on the evolving state of the art management of gastrointestinal stromal tumoursZoltan Szucs, Robin L JonesClinical Pharmacology : Advances and Applications|December 23, 2017
Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcomaAlexandra Pender, Robin L JonesJournal of Surgical Oncology|December 2, 2017
Systemic therapy in retroperitoneal sarcoma managementAnastasia Constantinidou, Robin L JonesFuture Oncology (London, England)|August 18, 2023
Ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor after treatment with imatinib: a plain language summary of the phase 3 INTRIGUE trialMarina Symcox, Robin L JonesFuture Oncology (London, England)|July 27, 2017
Olaratumab for the treatment of soft-tissue sarcomaAlexandra Pender, Robin L JonesGMS Ophthalmology Cases|September 15, 2016
The management of ophthalmic involvement in blue rubber bleb nevus syndromeBradley Petek, Robin L JonesPageof 39